This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (66)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Conflict of Interest  • Medical Ethics  • Patient-Physician Relationship/ Care  • Patient Education/ Health Literacy  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Sarah E. Gollust, BA; Sara Chandros Hull, PhD; Benjamin S. Wilfond, MD

JAMA. 2002;288:1762-1767.

Although direct-to-consumer (DTC) advertisements for pharmaceuticals have been appearing in the mass media for 20 years, DTC advertisements for genetic testing have only recently appeared. Advertisements for genetic testing can provide both consumers and physicians with information about test availability in an expanding market. However, 3 factors limit the value and appropriateness of advertisements: complex information, a complicated social context surrounding genetics, and a lack of consensus about the clinical utility of some tests. Consideration of several advertisements suggests that they overstate the value of genetic testing for consumers' clinical care. Furthermore, advertisements may provide misinformation about genetics, exaggerate consumers' risks, endorse a deterministic relationship between genes and disease, and reinforce associations between diseases and ethnic groups. Advertising motivated by factors other than evidence of the clinical value of genetic tests can manipulate consumers' behavior by exploiting their fears and worries. At this time, DTC advertisements are inappropriate, given the public's limited sophistication regarding genetics and the lack of comprehensive premarket review of tests or oversight of advertisement content. Existing Federal Trade Commission and Food and Drug Administration regulations for other types of health-related advertising should be applied to advertisements for genetic tests.

Author Affiliations: Medical Genetics Branch, National Human Genome Research Institute, and Department of Clinical Bioethics, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Direct-to-Consumer Advertising of Genetic Testing

JAMA. ;289():45-46.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

DTC Advertising Harms Patients and Should Be Tightly Regulated.
Lurie
J Law Med Ethics 2009;37:444-450.
 

Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian Cancer
Gray et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1303-1311.
ABSTRACT | FULL TEXT  

Public Awareness and Use of Direct-to-Consumer Genetic Tests: Results From 3 State Population-Based Surveys, 2006
Goddard et al.
AJPH 2009;99:442-445.
ABSTRACT | FULL TEXT  

Assessing the social meaning, value and implications of research in genomics
Lumbreras et al.
J. Epidemiol. Community Health 2007;61:755-756.
FULL TEXT  

Incorporating Pharmacogenomics into Practice
Ellingrod and Moline
Journal of Pharmacy Practice 2007;20:277-282.
ABSTRACT  

Risk Communication During Screening for Genomic Breast Cancer Susceptibility
Gramling and Vidrine
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:54-58.
ABSTRACT  

Regulatory Perspectives on Pharmacogenomics: A Review of the Literature on Key Issues Faced by the United States Food and Drug Administration
Phillips and Van Bebber
Med Care Res Rev 2006;63:301-326.
ABSTRACT  

Will Genetic Testing for Complex Diseases Increase Motivation to Quit Smoking? Anticipated Reactions in a Survey of Smokers
Sanderson and Wardle
Health Educ Behav 2005;32:640-653.
ABSTRACT  

Contributions of Public Health to Genetics Education for Health Care Professionals
Burke
Health Educ Behav 2005;32:668-675.
ABSTRACT  

Marketing Genetic Tests: Empowerment or Snake Oil?
Bowen et al.
Health Educ Behav 2005;32:676-685.
ABSTRACT  

Research and Practice Opportunities at the Intersection of Health Education, Health Behavior, and Genomics
Wang et al.
Health Educ Behav 2005;32:686-701.
ABSTRACT  

Ready for Genomic Medicine? Perspectives of Health Care Decision Makers
Billings et al.
Arch Intern Med 2005;165:1917-1919.
FULL TEXT  

Advertising by Academic Medical Centers
Larson et al.
Arch Intern Med 2005;165:645-651.
ABSTRACT | FULL TEXT  

Emerging Concepts in Nutrigenomics: A Preview of What Is to Come
Kauwell
Nutr Clin Pract 2005;20:75-87.
ABSTRACT | FULL TEXT  

Community Involvement in Developing Policies for Genetic Testing: Assessing the Interests and Experiences of Individuals Affected by Genetic Conditions
Gollust et al.
AJPH 2005;95:35-41.
ABSTRACT | FULL TEXT  

Public culture and public understanding of genetics: a focus group study
Bates
Public Understanding of Science 2005;14:47-65.
ABSTRACT  

Advertising, Patient Decision Making, and Self-referral for Computed Tomographic and Magnetic Resonance Imaging
Illes et al.
Arch Intern Med 2004;164:2415-2419.
ABSTRACT | FULL TEXT  

Does This Patient Have a Family History of Cancer?: An Evidence-Based Analysis of the Accuracy of Family Cancer History
Murff et al.
JAMA 2004;292:1480-1489.
ABSTRACT | FULL TEXT  

Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?
Humphries et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:628-636.
ABSTRACT | FULL TEXT  

Enthusiasm for Cancer Screening in the United States
Schwartz et al.
JAMA 2004;291:71-78.
ABSTRACT | FULL TEXT  

Cancer Genetics in Primary Care
McKelvey and Evans
J. Nutr. 2003;133:3767S-3772.
ABSTRACT | FULL TEXT  

The Use of Gene Tests to Detect Hereditary Predisposition to Chronic Disease: Is Cost-Effectiveness Analysis Relevant?
Col
Med Decis Making 2003;23:441-448.
ABSTRACT  

Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer Beware
Gray and Olopade
JCO 2003;21:3191-3193.
FULL TEXT  

Direct-to-Consumer Advertising of Genetic Testing
Levin
JAMA 2003;289:45-46.
FULL TEXT